Mitogen-activated protein kinase (MAPK) pathways regulate multiple cellular functions and are highly active in many types of human cancers. Apoptosis signal-regulating kinase 1 (ASK1) is an upstream MAPK involved in apoptosis, inflammation, and carcinogenesis. This study investigated the role of ASK1 in the development of gastric cancer. In human gastric cancer specimens, we observed increased ASK1 expression, compared to nontumor epithelium. Using a chemically induced murine gastric tumorigenesis model, we observed increased tumor ASK1 expression, and ASK1 knockout mice had both fewer and smaller tumors than wild-type (WT) mice. ASK1 siRNA inhibited cell proliferation through the accumulation of cells in G1 phase of the cell cycle, and reduced cyclin D1 expression in gastric cancer cells, whereas these effects were uncommon in other cancer cells. ASK1 overexpression induced the transcription of cyclin D1, through AP-1 activation, and ASK1 levels were regulated by cyclin D1, via the Rb-E2F pathway. Exogenous ASK1 induced cyclin D1 expression, followed by elevated expression of endogenous ASK1. These results indicate an autoregulatory mechanism of ASK1 in the development of gastric cancer. Targeting this positive feedback loop, ASK1 may present a potential therapeutic target for the treatment of advanced gastric cancer.
Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer Mitogen-activated protein kinase (MAPK) pathways regulate multiple cellular functions and are highly active in many types of human cancers. Apoptosis signal-regulating kinase 1 (ASK1) is an upstream MAPK involved in apoptosis, inflammation, and carcinogenesis. This study investigated the role of ASK1 in the development of gastric cancer. In human gastric cancer specimens, we observed increased ASK1 expression, compared to nontumor epithelium. Using a chemically induced murine gastric tumorigenesis model, we observed increased tumor ASK1 expression, and ASK1 knockout mice had both fewer and smaller tumors than wild-type (WT) mice. ASK1 siRNA inhibited cell proliferation through the accumulation of cells in G1 phase of the cell cycle, and reduced cyclin D1 expression in gastric cancer cells, whereas these effects were uncommon in other cancer cells. ASK1 overexpression induced the transcription of cyclin D1, through AP-1 activation, and ASK1 levels were regulated by cyclin D1, via the Rb-E2F pathway. Exogenous ASK1 induced cyclin D1 expression, followed by elevated expression of endogenous ASK1. These results indicate an autoregulatory mechanism of ASK1 in the development of gastric cancer. Targeting this positive feedback loop, ASK1 may present a potential therapeutic target for the treatment of advanced gastric cancer.
JNK | c-Jun G astric cancer (GC) is a common cancer worldwide, associated with a high mortality despite its declining incidence in recent decades. Smoking, salted or smoked foods, and Helicobacter pylori appear to be major environmental inducers of GC (1) (2) (3) . Although the role of H. pylori in causing mucosal effects has been investigated, which molecular signal(s) initiate the program of irreversible transformation remain unclear, and thus molecular targeting therapies for GC have not been well established.
Mitogen-activated protein kinase (MAPK) pathways are important for the development of gastric tumorigenesis (4). Apoptosis signal-regulating kinase 1 (ASK1) is a ubiquitously expressed MAPK kinase kinase (MAP3K), activated by various stress stimuli, including reactive oxygen species (ROS), TNF-α, and LPS (5-7). ASK1 activates the JNK and p38 signaling pathways and is required for both oxidative stress and cytokine-induced apoptosis (5) . Furthermore, ASK1 affects multiple cellular functions, including survival, differentiation, and the innate immune response (5, 7, 8) and has been reported to be involved in the pathogenesis of various human diseases, including neurodegenerative (9), cardiovascular (10) , and inflammatory diseases (11, 12) . Additionally, ASK1 has been shown to participate in both colon (12) and skin (13) tumorigenesis through the regulation of inflammation and apoptosis. However, no reported study has demonstrated a role for ASK1 in gastric tumorigenesis.
In this study, we examined the role of ASK1 in gastric tumorigenesis using both human GC samples and ASK1-deficient (ASK1 −/− ) mice. We demonstrated that ASK1 is important for gastric tumorigenesis through the regulation of cyclin D1 expression. Furthermore, we validated an ASK1-dependent positive feedback loop controlling cyclin D1 expression in GC cells as a potential anticancer target.
Results

Increased Expression of ASK1 in Human Gastric
Cancer. To analyze the involvement of ASK1 in GC, we first examined expression levels of ASK1 in gastric tissue specimens. We observed that the levels of ASK1 were significantly elevated in GC samples compared to nontumor gastric epithelium (Fig. 1A) . Additionally, we observed that the levels of cyclin D1 and phosphorylated JNK in GC were higher than in nontumor epithelium. We tested 66 samples from nontumor or tumor tissues of patients with GC by immunoblotting and quantified ASK1 expression using densitometry. We observed significantly increased ASK1 expression in GC (P = 0.002; Fig. 1B ), confirming that ASK1 was up-regulated in GC cells.
Next, to examine whether ASK1 expression increased in other cancers, we compared ASK1 expression in colon cancer and nontumor colon epithelium. Unlike gastric tissues, we found no difference in ASK1 expression between nontumor and tumor tissues ( Fig. 1 C and D) . These results suggest that the up-regulation of ASK1 is specific to GC and may play a significant role in carcinogenesis.
Next, we investigated the expression of ASK1 in cultured GC cell lines. Among the 29 GC cell lines analyzed, ASK1 expression was detected in 23 cell lines by immunoblotting. Phosphorylation of JNK was enhanced in the majority of cell lines displaying elevated ASK1 expression (Fig. 1E) . Immunoprecipitation analysis revealed constitutive ASK1 activation in several GC cell lines, suggesting that ASK1 expression and its activity are elevated in gastric tumor cells (Fig. 1F ).
ASK1 Enhances MNU-Induced Gastric Tumorigenesis in Mice. To examine the role of ASK1 in GC, we used a mouse model of chem-ically induced gastric tumorigenesis. As the administration of N-methyl-N-nitrosourea (MNU) results in efficient gastric tumor induction in mice (14) , wild-type (WT) and ASK1 −/− mice were administered MNU as described previously ( Fig. 2A) . Histological analysis showed no significant difference between control WT and ASK1 −/− mice. After MNU treatment, the number of detectable gastric tumors was significantly lower in ASK1 −/− mice (0.30 ± 0.15) than in WT mice (1.40 ± 0.34). The average size of these tumors was also smaller in ASK1 −/− mice (0.90 ± 0.30) than those in WT mice (2.20 ± 0.40; Fig. 2 B and C) and these tumors available for histological evaluation showed moderate-to-severe dysplasia.
Then, we investigated the expression of ASK1 and its downstream signaling partners using immunohistochemical and immunoblot analyses. The levels of phosphorylated JNK, p38, and total c-Jun were higher in tumor sections of WT mice than ASK1 −/− mice ( Fig. 2 D and E) . TUNEL staining showed few apoptotic cells in nontumor and tumor epithelium in both genotypes. The expression of ASK1 was elevated in tumor sections of WT mice, compared to nontumor epithelium ( Fig. 2E and Fig. S1A ), as observed in human gastric tissue specimens. In contrast, in murine colitis-associated tumors analyzed previously (12) , levels of ASK1 expression were similar to those in nontumor epithelium (Fig. S1B ). These data indicate that ASK1 may play an especially important role in the development of GC.
ASK1 Is Important for Cell Proliferation in Gastric Cancer Cells. To examine whether ASK1 affected tumor growth in vitro, we treated the GC cell lines AGS, MKN45, MKN74, and TMK1 with a control small interfering RNA (NCsiRNA) or ASK1-specific siRNA (ASK1siRNA; Fig. 3A ). Cell proliferation was significantly inhibited following ASK1siRNA transfection, in a dose-dependent manner (Fig. 3B) , and decreased proliferation caused by ASK1siRNA was observed in all four GC cell lines examined (Fig.  3C ). Next, we investigated the role of ASK1 in the cell cycle status of GC cells using flow cytometry. ASK1siRNA transfected cells displayed a higher proportion of cells in the G0/G1 phase than cells transfected with NCsiRNA ( Fig. 3 D and E) .
We also evaluated the proliferative effect of ASK1 in nontransformed gastric cells. In the rat normal gastric cell line RGM1, ASK1 knockdown did not reduce cell proliferation ( Fig.  S2 B and C). We also analyzed the cell cycle of gastric epithelial cells isolated from WT and ASK1 −/− mice, using FACS. Consistent with the normal development of gastric epithelial cells in ASK1 −/− mice, epithelial cells from ASK1 −/− mice showed similar cell cycle status to cells from WT mice (Fig. S2 A, D , and E). These results suggested that ASK1 silencing altered the rate of proliferation in GC cells, but not in normal cells without malignant transformation. To investigate the mechanism of cell cycle regulation, we examined the expression of cell cycle-associated genes in AGS cells transfected with NC or ASK1siRNA. Among the 84 genes examined, cyclin D1, a known regulator of the G1-to-S phase transition (15) , was significantly down-regulated by ASK1siRNA transfection, whereas both HERC5 and Bcl-2 were up-regulated (Fig. 4A and Table S1 ; fourfold cutoff). When we examined the effect of ASK1 knockdown in GC cells, we found reduced cyclin D1 protein levels in addition to reduced expression of c-Jun and phosphorylated JNK, with no effect on cyclins A, E, or H protein levels (Fig. 4B ). These data were consistent with the results obtained from the MNU-treated mouse gastric tumor that revealed decreased cyclin D1 and proliferating cell nuclear antigen (PCNA) levels in tumors from ASK1 −/− mice (Fig. S2 F and G) , but not in control mice (Fig. S2A) . To confirm the regulation of cyclin D1 expression by ASK1, we overexpressed ASK1 using recombinant adenoviruses and expression plasmids (6, 16, 17) . Immunoblot analysis showed increased c-Jun and cyclin D1 expression levels in cells infected with the adenoviruses encoding WT ASK1 (ASK-WT) compared to those infected with β-galactosidase (LacZ) in the AGS and MKN74 GC cell lines (Fig. 4C) .
JNK is a critical signal transducer of the AP-1 transcription factor, and AP-1 activates the cyclin D1 promoter via an AP-1 binding site. To examine the role of ASK1 in this cyclin D1 transactivation, we performed a luciferase assay using the cyclin D1 promoter-containing construct pD1luc (18) and consensus AP-1 binding site-containing AP-1luc. As shown in Fig. 4 D and E, ASK1-WT enhanced both the cyclin D1 promoter and AP-1 transcription factor in AGS cells. Further, kinase-mutant ASK1 (ASK1-KM) failed to enhance these luciferase activities in addition to the c-Jun and cyclin D1 protein levels (Fig. 4 C, D , and E), indicating that ASK1 regulates both AP-1 activity and cyclin D1 expression in a kinase-dependent manner. Mutagenesis of the cyclin D1 promoter at the AP-1 binding site abolished the enhanced promoter activity induced by ASK1 overexpression (Fig. 4F) , ensuring that ASK1 regulates cyclin D1 transcription via AP-1 activation.
To examine whether the regulation of cyclin D1 protein and cell proliferation by ASK1 is specific to GC, we used several cell lines derived from other tumor types. In contrast to gastric cancer cells, most of the colon and pancreatic cancer cell lines did not show reduced cyclin D1 expression by ASK1 knockdown (Fig. 4G) . We found that ASK1 silencing reduced cyclin D1 protein levels in some cancer cell lines, such as ASPC-1 and DLD-1 (Fig. S3A ), but these cell lines did not show enhanced cyclin D1 levels on ASK1 overexpression (Fig. S3B) . Additionally, ASK1 silencing did not affect cell proliferation in these colon, pancreatic, or lung cancer cell lines (Fig. S3C) , suggesting that the ASK1-dependent regulation of the cyclin D1 level and cellular proliferation is specific to GC.
Positive Feedback Regulation of ASK1 by Cyclin D1. Epidermal growth factor (EGF) regulates cell growth, proliferation, and differentiation, and plays an important role in GC or precancerous lesions (19) (20) (21) . EGF activates both the extracellular signal-regulated kinases (ERKs) and JNKs (22) (23) (24) and induces cyclin D1 transcription through AP-1 activation (25, 26) . When AGS cells were treated with EGF, ASK1 phosphorylation was enhanced, suggesting that EGF stimulates ASK1 activation (Fig.  5A ). EGF stimulation also induced JNK phosphorylation and increased cyclin D1 expression and phosphorylation of the retinoblastoma protein, Rb, in NCsiRNA transfected cells, but not in ASK1siRNA transfected cells (Fig. 5B ). Rb regulates cell cycle progression, cooperating with the cyclin and the cyclin-dependent kinase (CDK) family (15) . Phosphorylation of Rb by CDKs inhibits Rb-E2F binding, allowing E2F activation and cell cycle progression (27) , whereas the phosphorylation of Rb at Ser780 requires cyclin D1 (28, 29) .
Because ASK1 has been reported to be a direct target of the E2F transcription factor (30, 31), we investigated whether ASK1 expression was itself regulated by cyclin D1. We observed that following stimulation with EGF, ERK phosphorylation was induced in both NCsiRNA-and cyclin D1-specific siRNA (CyD1siRNA)-transfected cells, but the increase in cyclin D1 and Ser780 phosphorylation of Rb was induced only in control cells (Fig. 5C) . Additionally, we found that the expression of ASK1 was elevated following EGF treatment in control cells, but not in cyclin D1-silenced cells (Fig. 5C and Fig. S4A ), whereas the expression of another major MAP3K, TGF-β-activated kinase 1 (TAK1), was not affected. To further confirm this observation, we overexpressed cyclin D1 in these cells. Overexpression of cyclin D1 enhanced the phosphorylation of Rb, followed by increased ASK1 expression (Fig. 5D) , suggesting that the regulation of ASK1 expression was cyclin D1 dependent.
Finally, we investigated the role of ASK1 and cyclin D1 in ASK1 promoter activation. As expected, cyclin D1 overexpression induced E2F transcriptional activation (Fig. S4B) . A chromatin immunoprecipitation (ChIP) assay showed that cyclin D1 expression increased E2F1 binding to the ASK1 promoter (Fig. 5E ). Furthermore, treatment of cells with an adenovirus encoding a constitutively active mutant of ASK1 (ASK-ΔN) (16) enhanced JNK phosphorylation and cyclin D1 expression, resulting in an increase in endogenous ASK1 (Fig. 5F ). In the ChIP assay, E2F1 binding to the ASK1 promoter was increased in cells expressing exogenous ASK1 (Fig. 5G) . Collectively, these data indicate that ASK1 regulates the expression of cyclin D1, which, in turn, regulates the expression of ASK1 in GC through the Rb-E2F pathway (Fig. 5H) .
Discussion
Although the role of ASK1 in carcinogenesis has been reported, most studies have focused on ASK1-mediated apoptosis or inflammatory responses, rather than cellular proliferation. Indeed, several in vivo analyses revealed that ASK1 is a critical regulator of apoptosis in liver, heart, and nerve tissue and a regulator of inflammation in the skin and colon (10) (11) (12) (13) 32) . This study showed that the expression of ASK1 was elevated in human GC tissue. Furthermore, we demonstrated that ASK1 is important for gastric tumorigenesis in mice and regulates cell proliferation and cell cycle progression through controlling cyclin D1 expression in GC cells. These results suggest that ASK1 plays an important role in GC that is not mediated through either apoptosis or inflammatory effects.
MAPKs are important signaling components that convert extracellular stimuli into a wide variety of cellular responses including proliferation, differentiation, and apoptosis (33) . MAPK pathways consist of three classes of protein kinases: MAPK, MAP2K, and MAP3K. MAP3Ks provide the specificity for stimulus-dependent activation of downstream kinases (34) . To date, 21 MAP3Ks are known to activate MAP2Ks, but these have rarely been investigated in the pathogenesis of GC. BRAF, which transduces mitogenic stimuli from Ras leading to ERK1/2 activation, is reportedly mutated in 2% of GC cases (35) . JNKs regulate multiple cellular functions including carcinogenesis, through activation of the AP-1 transcription factor. We previously reported that the JNK signaling pathway is critical in the development of GCs (4), whereas its mechanism of activation remains unclear. Thus, we examined the function of ASK1 in GC cells as one of the MAP3Ks that possesses the ability to activate the JNK pathway. In this study, we found that ASK1 silencing reduced JNK phosphorylation, indicating that ASK1 is a critical regulator of JNK signaling in GC. When we compared the effects of ASK1 inhibition with the JNK1-or JNK2-mediated inhibition of cellular proliferation, ASK1 silencing resulted in greater inhibition of cellular proliferation than either JNK1 or JNK2 silencing (Fig. S5A) . In GC cells, ASK1siRNA was able to reduce both JNK1 and JNK2 activation (Fig. S5B) , suggesting that ASK1 mediates proliferation through both these kinases.
There is a wealth of evidence showing how the disturbance of specific cyclins plays an important role in many types of human cancer. In GC, the cyclin E gene is amplified in 15-20% of gastric cancers, whereas cyclin B2 or cyclin C is also up-regulated (36) . Amplification or mutation of the cyclin D1 gene has not been reported in GC, although elevated cyclin D1 expression has been observed in ≈50% of GC cases (37) . In GC, several factors are reportedly involved in cyclin D1 overexpression, including the RAF/MEK/ERK pathways (38) , abrogation of TGF-β signaling (39) , gastrin (40, 41) , Epstein-Barr virus (42) , and H. pylori (43) . However, the precise mechanism that regulates cyclin D1 expression in GC remains unclear. In this report, we describe a unique mechanism of cyclin D1 overexpression through an ASK1-cyclin D1 feedback loop.
The associations between ASK1, cyclin D1, and cellular proliferation seemed specific to GC cells, because ASK1 knockdown in other cell lines did not inhibit proliferation and ASK1 overexpression did not increase cyclin D1 protein levels. We found increased levels of ASK1 caused by cyclin D1 overexpression in many cell types (Fig. S6A ), which could be explained by the effect of E2F on the ASK1 promoter, as reported previously in colon and melanoma cell lines (30, 31) . Thus, the enhancement of cyclin D1 and cell proliferation by ASK1 is specific to GC. The discrepancies between the MNU-induced gastric tumorigenesis model in this study and the colitis-associated colon cancer model in which we previously demonstrated that ASK1 deficiency promoted tumorigenesis may also demonstrate the specificity of the ASK1-cyclin D1 feedback loop in gastric tumorigenesis. In other types of cancer, the mutation of specific genes, such as APC or β-catenin in colon cancer or K-ras in pancreatic cancer, has been reported to lead to cyclin D1 overexpression and carcinogenesis (44) (45) (46) (47) . Although no major mutation leading to cyclin D1 overexpression has been reported in GC, the ASK1-mediated positive feedback loop containing cyclin D1 (Fig. 5H ) may play a role in tumorigenesis equivalent to the genetic alteration observed in other types of cancer, suggesting that ASK1 may be a potential therapeutic target for GC.
We used a MNU model of murine gastric tumorigenesis in this study, although there are many other models that can be used to evaluate the role of host genetics. For example, some studies used Helicobacter as a driver of inflammation and found important cytokines, signaling molecules, and potential stem cells that act in gastric tumorigenesis (48) (49) (50) (51) (52) . Because the MNU model induces little inflammation, we think that this model is useful for analyzing the pure proliferative effect of ASK1 in gastric epithelium. We also investigated the role of ASK1 in cell proliferation caused by H. pylori infection in a short-term model. H. pylori infection induced gastric cellular hyperplasia in infected WT mice. Increased ASK1 and cyclin D1 levels were also observed following infection. In ASK1 −/− mice, gastric hyperplasia and cyclin D1 up-regulation were also observed in infected mice, but these changes were not as prominent as in WT mice (Fig. S6 B  and C) . These findings suggest the involvement of ASK1 in H. pylori-induced gastritis. To determine the role of ASK1 in H.
pylori-induced gastric tumorigenesis, a long-term infection model may be required.
In summary, we demonstrated that ASK1 regulated the expression of cyclin D1, which, in turn, regulated ASK1 expression in a positive feedback system in GC cells. These results indicate an essential role of ASK1 in gastric carcinogenesis and suggest the potential of specific ASK1-targeting therapies for GC.
Materials and Methods
Mice and Gastric Tumorigenesis Model. The generation of ASK1 −/− mice has been described previously (8) . ASK1 −/− mice were backcrossed into the C57BL/6 strain at least 14 times and both ASK1 −/− mice and C57BL/6 WT mice (Clea Japan) were used in the study. All of the experimental protocols were approved by the ethics committee for animal experimentation and conducted in accordance with the Guidelines for the Care and Use of Laboratory Animals of the Graduate School of Medicine, the University of Tokyo, and the Institute for Adult Diseases, Asahi Life Foundation.
For the gastric tumorigenesis model, 6-wk-old WT and ASK1 −/− mice were given drinking water containing 240 ppm of MNU (Sigma Chemicals) on alternate weeks for a total of 5 wk of exposure, as described previously (53) . Forty weeks after beginning MNU administration, the stomach was removed, opened along the greater curvature, and stained with indigo carmine. The number and long diameter of tumors in the stomach were measured under a dissecting microscope. Tumors >0.5 mm in diameter were mapped and counted in a blinded fashion.
Human Tissue Samples. Clinical tissue specimens from patients were obtained from the archives of University of Tokyo Hospital and Motojima General Hospital with the approval of the medical ethics committee and with informed consent.
Cell Lines. The human cancer cell lines were cultured in Ham's F-12, DMEM, or RPMI medium, supplemented with 10-20% FBS. Cell numbers were determined using a Cell Counting Kit-8 according to the manufacturer's protocol (Dojindo Laboratories).
Cell Cycle Analysis by Flow Cytometry. The proportion of cells in either G0/G1, S, or G2/M phase was determined by flow cytometric analysis of DNA content. Briefly, cells obtained by trypsinization were washed with PBS and incubated in propidium iodide solution (50 mg/mL in PBS) for 30 min. The cells were then analyzed for cell cycle status using the Guava EasyCyte Plus (Guava Technologies).
ChIP Assays. Chromatin immunoprecipitation was performed essentially as described (54) . Antibodies to E2F1 (sc-193; Santa Cruz) were used to precipitate chromosomal DNA, using cross-linked chromatin prepared from exponentially growing cells. The immunoprecipitated DNA was analyzed by PCR using the ASK1 promoter region primers 5′-GAGTGGGTGGCCAGAAGC and 5′-CGGAGCTTCCTTTTCTTGGC.
Statistical Analyses. The differences between means were compared using Student's t-test or the Wilcoxon test. P values < 0.05 were considered significant. Please see SI Materials and Methods for details.
